Sjögren's Syndrome
Showing 1 - 25 of >10,000
Superb Microvascular Imaging Ultrasonography of Lacrimal Gland
Recruiting
- Inflammation
- +2 more
- Superb Microvascular Imaging (SMI) (Toshiba)
-
Niğde, TurkeyNigde Omer Halisdemir University
Jan 10, 2023
Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)
Not yet recruiting
- Primary Sjögren's Syndrome
- Efgartigimod
- Placebo
- (no location specified)
Apr 5, 2023
Dry Eye Syndrome, Sjogren's Syndrome, Xerophthalmia Trial in Taipei (Chinese herbal tea VGH-DESJS-1)
Not yet recruiting
- Dry Eye Syndrome
- +2 more
- Chinese herbal tea VGH-DESJS-1
-
Taipei, TaiwanChing-Mao Chang
Dec 19, 2022
Sjogren's Syndrome Trial (Anifrolumab)
Recruiting
- Sjogren's Syndrome
- Anifrolumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Dec 16, 2022
HRR as a Novel Biomarker in Sjögren's Syndrome
Completed
- Sjögren's Syndrome
- blood sample analysis
-
Tianjin, Tianjin, ChinaTianjin Eye Hospital
Nov 30, 2022
Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)
Recruiting
- Sjögren's Syndrome
- low-dose interleukin-2
- rapamycin
-
Beijing, Beijing, ChinaPeking university people's hospital
Dec 2, 2022
Sjögren and Gynecologic Considerations
Completed
- Primary Sjögren Syndrome
- +3 more
- Visual analogue scale (VAS) for dyspareunia
- +3 more
-
Ankara, TurkeyAnkara City Hospital
Jan 3, 2023
AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal
Completed
- Sjogren's Syndrome
- +2 more
- Autologous serum tears combined with 0.05% cyclosporin eye drop
-
Chengdu, Sichuan, ChinaHospital of Chengdu University of Traditional Chinese Medicine
Aug 25, 2023
Dental and Periodontal Status of Sjögren's Syndrome.
Recruiting
- Sjögren Syndrome
- Salivary samples
-
Ivry-sur-Seine, Ile De France, FranceService de Médecine bucco-dentaire
Oct 28, 2022
Sjogren Syndrome With Other Organ Involvement Trial (Hydroxychloroquine, Tacrolimus)
Not yet recruiting
- Sjogren Syndrome With Other Organ Involvement
- (no location specified)
Dec 28, 2022
Sjogren Syndrome With Other Organ Involvement Trial (Prednisolone, Tacrolimus)
Not yet recruiting
- Sjogren Syndrome With Other Organ Involvement
- (no location specified)
Jan 12, 2023
Sjögren's Syndrome, Xerostomia, Dysphagia Trial (Tongue, lip, chin exercise group)
Not yet recruiting
- Sjögren's Syndrome
- +3 more
- Tongue, lip, chin exercise group
- (no location specified)
Dec 25, 2022
Physician Consideration of ePRO's, From Gout, Rheumatoid
Not yet recruiting
- Gout
- +3 more
- Therapeutic management following access by the physician to his patient's ePROs
- (no location specified)
Jun 22, 2023
Sjogren's Syndrome, Interstitial Lung Disease, Organizing Pneumonia Trial in Stanford
Suspended
- Sjogren's Syndrome
- +7 more
-
Stanford, CaliforniaStanford University
Oct 25, 2022
Different Subtypes of Primary Sjogren Syndrome Related Dry Eye
Recruiting
- Dry Eye
- Cyclosporine
-
Beijing, ChinaPeking University Third Hospital
Oct 30, 2022
Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)
Completed
- Primary Sjögren Syndrome
-
Rochester, New YorkUniversity of Rochester
Jul 6, 2022
Primary Sjögren Syndrome Patients
Active, not recruiting
- Sjogren's Syndrome
- Parallel Assignment
-
São Paulo, Sao Paulo, Brazil
- +1 more
Nov 7, 2022
Sjogren's Syndrome, Dry Eye Trial (Varenicline Nasal Spray)
Not yet recruiting
- Sjogren's Syndrome
- Dry Eye
- Varenicline Nasal Spray
- (no location specified)
Jan 26, 2023
Sjogren Syndrome Trial (VAY736, Placebo)
Not yet recruiting
- Sjogren Syndrome
- VAY736
- Placebo
- (no location specified)
Jul 14, 2022
Sjögren, Sjögren Syndrome Trial in Antalya (Pelvic floor exercises)
Completed
- Sjögren
- Sjögren Syndrome
- Pelvic floor exercises
-
Antalya, TurkeyAntalya Training and Research Hospital
Oct 11, 2022
Sjogren Syndrome Trial (VAY736, Placebo)
Not yet recruiting
- Sjogren Syndrome
- VAY736
- Placebo
- (no location specified)
Jul 14, 2022
Healthy Participants, Primary Sjögren's Syndrome Trial in Berlin (BMS-986325, Placebo for BMS-986325)
Recruiting
- Healthy Participants
- Primary Sjögren's Syndrome
- BMS-986325
- Placebo for BMS-986325
-
Berlin, GermanyLocal Institution - 0001
Jul 11, 2022